Minimed Group/$MMED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Minimed Group
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.
Ticker
$MMED
Sector
Primary listing
Employees
8,000
Headquarters
Website
Minimed Group Metrics
BasicAdvanced
$5bn
-
-$1.30
-
-
Price and volume
Market cap
$5bn
52-week high
$20.48
52-week low
$10.65
Average daily volume
1.2m
Financial strength
Current ratio
1.92
Quick ratio
1.358
Long term debt to equity
1.246
Total debt to equity
1.762
Profitability
EBITDA (TTM)
278
Gross margin (TTM)
57.06%
Net profit margin (TTM)
-10.67%
Operating margin (TTM)
3.93%
Effective tax rate (TTM)
-68.45%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
1.73%
Return on equity (TTM)
-9.28%
Valuation
Price to revenue (TTM)
1.462
Price to book
1.43
Price to tangible book (TTM)
3.98
Price to free cash flow (TTM)
-10.796
Free cash flow yield (TTM)
-9.26%
Free cash flow per share (TTM)
-1.637
Growth
Revenue change (TTM)
14.25%
Earnings per share change (TTM)
54.29%
3-year revenue growth (CAGR)
11.38%
What the Analysts think about Minimed Group
Analyst ratings (Buy, Hold, Sell) for Minimed Group stock.
Minimed Group Financial Performance
Revenues and expenses
Minimed Group Earnings Performance
Company profitability
Minimed Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.